Randomized Placebo-Controlled Trial of Anacetrapib (REVEAL)

Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts News Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Empagliflozin in the Treatment of Chronic Heart Failure Pulmonary Embolism Pulsed Field Ablation

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Topics

Content Type

Journals

Faculty

Events

Resource Hubs

Video

ESC 2017: The REVEAL Study - Randomized Placebo-Controlled Trial of Anacetrapib

Published: 15 Sep 2017

Views:
459
Likes:
0

Average (ratings)

No ratings

Your rating

This interview with Christopher P. Cannon from Brigham and Women's Hospital, Boston, US discusses Randomized Placebo-Controlled Trial of Anacetrapib in 30,449 Patients with Atherosclerotic Vascular Disease (REVEAL).

Filmed by Radcliffe Cardiology on-site at ESC 2017.